Stocks · News reference

Maravai LifeSciences' TriLink BioTechnologies Obtains New Patent From The China National Intellectual Property Administration, Patent Number ZL 2025 1 1246578.X

Jul 20, 2026, 8:05 PMBenzinga Newsdesk

TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ:MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

MRVI

Source: benzinga
Observed: Jul 20, 2026, 8:05 PM
Checked: Jul 20, 2026, 8:05 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 20, 2026, 3:06 PMAvi Kapoor
Deere, Coinbase Global, Nordson And Other Big Stocks Moving Higher On Wednesday
Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX, SCSC, BTBT, MRVI, HIVE, AHG, TEM, MARA, LB also gain.
Read original at benzinga
AHG ANDG BTBT CAI COIN
BenzingaAug 19, 2026, 4:15 PMBenzinga News-desk
Shares of mRNA cancer vaccine-related companies are trading higher amid sympathy with Merck and Moderna after they announced that intismeran autogene with KEYTRUDA yielded recurrence-free survival in patients with completely resected stage IIB-IV melanoma.
Read original at benzinga
BNTX IBRX MRVI PFE SLS
BenzingaAug 19, 2026, 2:08 PMAvi Kapoor
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting strong Q4 results and positive sales guidance.
Read original at benzinga
ARIS ASTL BNTX COTY CRSP
BenzingaAug 7, 2026, 2:09 PMBenzinga Newsdesk
Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $6.5
Wells Fargo analyst Evan Stampler maintains Maravai LifeSciences (NASDAQ:MRVI) with a Overweight and raises the price target from $5.5 to $6.5.
Read original at benzinga
MRVI

Maravai LifeSciences' TriLink BioTechnologies Obtains New Patent From The China National Intellectual Property Administration, Patent Number ZL 2025 1 1246578.X

Connected markets

Related headlines

Deere, Coinbase Global, Nordson And Other Big Stocks Moving Higher On Wednesday

Shares of mRNA cancer vaccine-related companies are trading higher amid sympathy with Merck and Moderna after they announced that intismeran autogene with KEYTRUDA yielded recurrence-free survival in patients with completely resected stage IIB-IV melanoma.

Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday

Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $6.5